Lidong Qin, PhD

  • Recruited to: The Methodist Hospital Research Institute
  • Recruited from: California Institute of Technology
  • Award: First-Time, Tenure-Track Faculty Member

Dr. Lidong Qin received his PhD degree in Chemistry from the Northwestern University, Evanston, Illinois before postdoctoral training in cancer nanotechnology at the California Institute of Technology (Caltech). He joined The University of Texas Health Science Center at Houston faculty in July 2010 as an Assistant Professor, in the Department of Nanomedicine and Biomedical Engineering. Dr. Qin proposes to develop integrated proteomic micro-devices for informative cancer diagnosis, malignancy assessment and study of molecular networks in the cancer microenvironment. His studies will provide helpful understanding in prostate cancer at different disease stages.

As a graduate student under the supervision of Prof. Chad Mirkin at Northwestern University, Dr. Qin worked on functional metallic nanorodswith the invention of on-wire lithography and the development of Raman spectrum-based imaging and sensing methods. His research provided insightful understanding in Surface Enhanced Raman Spectroscopy and Surface Plasmon Resonance, which are the basics of Raman-based cancer imaging and nanomaterials based cancer thermal therapeutics. Because of his pioneering work in metal nanomaterial synthesis and biological applications, he was awarded the International Precious Metal Institute (IPMI) graduate student prize. His other awards include the Materials Research Society graduate student award, Chinese government award for graduate students studying abroad, and many others. At Caltech, he worked with Prof. James Heath and developed automatic proteomic barcode chips that allow highly multiplexed plasma cancer biomarker measurements from a finger-prick of blood. The method is recognized as a significant improvement over the cost and speed of standard laboratory tests to analyze proteins in blood. Trained as a chemist, with intensive research work at two of NCI’sCenters for Cancer Nanotechnology Excellence (CCNE), Dr. Qin is recognized as an expert in technology development for cancer diagnosis, prevention, and treatment.

Here in Texas, Dr. Qin proposes to develop integrated proteomic micro-devices for informative cancer diagnosis, malignancy assessment and study of molecular networks in the cancer microenvironment. His studies will provide helpful understanding in prostate cancer at different disease stages.